Search research articles
Contact Us
Filters
Showing results (391-400 of 408) with videos related to
Page
of 41
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 30, 2023
Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling
Ha Na Kim, Zehra Elgundi, Xiaoting Lin, et al.
Nature Communications
|
March 20, 2026
The relative role of direct orbital forcing versus CO<sub>2</sub> and ice feedbacks on Quaternary climate
C J R Williams, N S Lord, A T Kennedy-Asser, et al.
Physical Review Letters
|
April 6, 2001
Experimental confirmation of the predicted shallow donor hydrogen state in zinc oxide
S F Cox, E A Davis, S P Cottrell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 22, 2000
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients
J G Slatter, L J Schaaf, J P Sams, et al.
Nature Materials
|
December 13, 2016
Temporal mapping of photochemical reactions and molecular excited states with carbon specificity
K Wang, P Murahari, K Yokoyama, et al.
Nature Materials
|
May 11, 2021
Reply to: On the observation of photo-excitation effects in molecules using muon spin spectroscopy
M Jingliang, K Wang, P Murahari, et al.
British Journal of Cancer
|
September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
Physical Review Letters
|
June 11, 2013
Importance of spin-orbit interaction for the electron spin relaxation in organic semiconductors
L Nuccio, M Willis, L Schulz, et al.
Clinical Breast Cancer
|
October 4, 2016
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5
John W Smith, Marc E Buyse, Priya Rastogi, et al.
The Review of Scientific Instruments
|
August 3, 2011
Design and commissioning of a high magnetic field muon spin relaxation spectrometer at the ISIS pulsed neutron and muon source
J S Lord, I McKenzie, P J Baker, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 408) with videos related to
Sort By:
Page
of 41
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 30, 2023
Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling
Ha Na Kim, Zehra Elgundi, Xiaoting Lin, et al.
Nature Communications
|
March 20, 2026
The relative role of direct orbital forcing versus CO<sub>2</sub> and ice feedbacks on Quaternary climate
C J R Williams, N S Lord, A T Kennedy-Asser, et al.
Physical Review Letters
|
April 6, 2001
Experimental confirmation of the predicted shallow donor hydrogen state in zinc oxide
S F Cox, E A Davis, S P Cottrell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 22, 2000
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients
J G Slatter, L J Schaaf, J P Sams, et al.
Nature Materials
|
December 13, 2016
Temporal mapping of photochemical reactions and molecular excited states with carbon specificity
K Wang, P Murahari, K Yokoyama, et al.
Nature Materials
|
May 11, 2021
Reply to: On the observation of photo-excitation effects in molecules using muon spin spectroscopy
M Jingliang, K Wang, P Murahari, et al.
British Journal of Cancer
|
September 15, 2011
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C K Lee, R J Simes, C Brown, et al.
Physical Review Letters
|
June 11, 2013
Importance of spin-orbit interaction for the electron spin relaxation in organic semiconductors
L Nuccio, M Willis, L Schulz, et al.
Clinical Breast Cancer
|
October 4, 2016
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5
John W Smith, Marc E Buyse, Priya Rastogi, et al.
The Review of Scientific Instruments
|
August 3, 2011
Design and commissioning of a high magnetic field muon spin relaxation spectrometer at the ISIS pulsed neutron and muon source
J S Lord, I McKenzie, P J Baker, et al.
Page
of 41